Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort

This naturalistic study analysed the association between cumulative lifetime antipsychotic dose and cognition in schizophrenia after an average of 16.5 years of illness. Sixty participants with schizophrenia and 191 controls from the Northern Finland Birth Cohort 1966 were assessed at age 43 years w...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Psychiatry Res
Main Authors: Husa, Anja P., Moilanen, Jani, Murray, Graham K., Marttila, Riikka, Haapea, Marianne, Rannikko, Irina, Barnett, Jennifer H., Jones, Peter B., Isohanni, Matti, Remes, Anne M., Koponen, Hannu, Miettunen, Jouko, Jääskeläinen, Erika
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier/North-Holland Biomedical Press 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5241225/
https://ncbi.nlm.nih.gov/pubmed/27888683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.psychres.2016.10.085
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares